Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Inclusion Criteria: * Medical diagnosis of Type 2 Diabetes; determined by review of subject-provided most recent Hg A1c. * Subject is under current care of a primary care provider or specialist * Clearance by medical provider to participate in diet, physical activity, and lifestyle changes * 18 years and above * Own a smartphone and be willing to install the Signos App to personally receive text messages or have access to a web-based survey to self-report their weight. * Willingness to complete quality of life questionnaires or other in-app surveys. * Willingness to use CGM device * Able to speak and read English * Be a Signos mHealth (mobile/web-based) user Exclusion Criteria: * Medical diagnosis of Type 1 Diabetes * Type 2 Diabetes currently using insulin or most recent A1c ≥10% * Severe hypoglycemia \<54 mg/dl resulting in seizure or unconsciousness, or requiring assistance/EMS/hospitalization - within 3 months prior to enrollment * Current medical diagnosis of an eating disorder (such as anorexia nervosa or bulimia) * Medical conditions (e.g., such as seizure disorder) requiring a specific medical diet. * Inborn error of metabolism such as phenylketonuria (PKU), glycogen storage disease, fructose intolerance, Maple Sugar Urine Disease (MSUD). * History of 10 or more soft tissue skin infections (such as cellulitis or abscesses) * Intolerable skin reaction from adhesive * Currently taking any of the following medications: Clozapine, Hydroxyurea, or any form of insulin.